Pathophysiology, Aetiology and Treatment of Gastroparesis

被引:28
作者
Sullivan, A. [1 ]
Temperley, L. [2 ]
Ruban, A. [3 ]
机构
[1] Homerton Univ Hosp, London, England
[2] Barts Hlth, London, England
[3] Imperial Coll, Dept Surg & Canc, London, England
关键词
Gastroparesis; Gastric emptying; Diabetes; Gut hormones; Digestion; GHRELIN; STOMACH; GLP-1; FOOD;
D O I
10.1007/s10620-020-06287-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Gastroparesis is characterized by delayed gastric emptying, with symptoms such as nausea, vomiting and abdominal pain, in the absence of mechanical obstruction. In most cases, it is idiopathic although diabetes mellitus is another leading cause. The physiology of gastric emptying is a complex process which is influenced by various inputs including the central nervous system, enteric nervous system and gut hormones. Developments in our understanding of gastroparesis have now demonstrated dysfunction in these systems, thus disrupting normal gastric emptying. Once mechanical obstruction is excluded, gastric scintigraphy remains the gold standard for diagnosis although wireless motility capsule and breath testing are alternative methods for diagnosis. Treatment for gastroparesis is challenging, and widely available therapies are often limited either by their poor evidence for efficacy or concerns over their long-term safety profile. Novel prokinetic agents have shown initial promise in clinical trials, and new endoscopic techniques such as gastric per-oral endoscopic myotomy are emerging. These new treatment modalities may provide an option in refractory gastroparesis with the adage of reduced morbidity compared to surgical treatments.
引用
收藏
页码:1615 / 1631
页数:17
相关论文
共 189 条
  • [1] Consensus Recommendations for Gastric Emptying Scintigraphy: A Joint Report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine
    Abell, Thomas L.
    Camilleri, Michael
    Donohoe, Kevin
    Hasler, William L.
    Lin, Henry C.
    Maurer, Alan H.
    McCallum, Richard W.
    Nowak, Thomas
    Nusynowitz, Martin L.
    Parkman, Henry P.
    Shreve, Paul
    Szarka, Lawrence A.
    Snape, William J., Jr.
    Ziessman, Harvey A.
    [J]. JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2008, 36 (01) : 44 - 54
  • [2] Abell TL, 2015, GASTROENTEROLOGY
  • [3] Abrahamsson H, 1969, ACTA PHYSL SCAND
  • [4] Prokinetics in Gastroparesis
    Acosta, Andres
    Camilleri, Michael
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2015, 44 (01) : 97 - +
  • [5] Ahn A, 2015, GASTROENTEROLOGY
  • [6] Altan E, 2012, EXPERT REV GASTROENT
  • [7] Cost-effectiveness of internet-based cognitive behavior therapy for irritable bowel syndrome: results from a randomized controlled trial
    Andersson, Erik
    Ljotsson, Brjann
    Smit, Filip
    Paxling, Bjorn
    Hedman, Erik
    Lindefors, Nils
    Andersson, Gerhard
    Ruck, Christian
    [J]. BMC PUBLIC HEALTH, 2011, 11
  • [8] ANI Pharmaceuticals, 2011, REGL TABL MED GUID
  • [9] Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis
    Arts, J.
    Holvoet, L.
    Caenepeel, P.
    Bisschops, R.
    Sifrim, D.
    Verbeke, K.
    Janssens, J.
    Tack, J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (09) : 1251 - 1258
  • [10] Atassi H, 2019, GASTROINTEST ENDOS C